GINDAMERAN
UNII WGT2OMP6LX

Substance Identification & Data

This profile provides standardized clinical and technical data for Gindameran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WGT2OMP6LX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2348560-89-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

WGT2OMP6LX

CAS Registry Number

2348560-89-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GINDAMERAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175791

National Cancer Institute reference terminology for clinical and research data.

INN ID

11477

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-141

Identifier assigned by the United States Adopted Names Council.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gindameran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GINDAMERAN

Common Names & Synonyms

BNT111 COMPONENT GINDAMERAN

BNT-111 COMPONENT NY-ESO-1 FUSION PROTEIN EXPRESSING RNA

FIXVAC RNA MELANOMA VACCINE COMPONENT EXPRESSING THE NY-ESO-1 FUSION PROTEIN T-CELL ANTIGEN

GINDAMERAN [INN]

GINDAMERAN [USAN]

GINDAMERAN [WHO-DD]

MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING CODON-OPTIMISED NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA ANTIGEN-1 (NY-ESO-1 CANCER/TESTIS ANTIGEN 1, CTAG1A) EXPRESSED AS A FUSION PROTEIN COMPRISING A SECRETORY SIGNAL PEPTIDE, NY-ESO-1, P2P16 TETANUS TOXOID-DERIVED HELPER EPITOPES AND A MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS I TRANSMEMBRANE AND CYTOPLASMIC DOMAIN (MITD), CONNECTED BY THREE GLYCINE/SERINE-RICH (GS) LINKER PEPTIDES, FLANKED BY 5' AND 3' UNTRANSLATED REGIONS AND A 3' POLY(A) TAIL.

RNA (RECOMBINANT (1,2-(M7GM-P-(P(R))-SP-P-G))-CAPPED HUMAN CANCER TESTIS ANTIGEN NY-ESO-1-SPECIFYING POLY(A)-TAILED MESSENGER RBL001.3), INNER SALT

RNA (RECOMBINANT (1,2-(M7GM-P-(P(R))-SP-P-G))-CAPPED HUMAN CANCER TESTIS ANTIGEN NY-ESO-1-SPECIFYING POLY(A)-TAILED MESSENGER RBL001.3), INNER SALT -